BCS Private Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.05M Sell
1,709
-429
-20% -$438K 0.62% 43
2026
Q1
$1.97M Buy
2,138
+460
+27% +$466K 0.6% 44
2025
Q4
$1.8M Hold
1,678
0.62% 42
2025
Q3
$1.28M Buy
1,678
+40
+2% +$29.8K 0.46% 49
2025
Q2
$1.28M Buy
+1,638
New +$1.27M 0.48% 45

Other funds holding LLY

BCS Private Wealth Management's LLY Position: Q2 2026 in Review

BCS Private Wealth Management reduced its Eli Lilly (LLY) stake by 20% in Q2 2026, selling an estimated $438K and leaving 1,709 shares worth $2.05M. The position accounts for 0.62% of the portfolio, ranked #43.

BCS Private Wealth Management first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • BCS Private Wealth Management held 1,709 shares of Eli Lilly worth $2.05M as of Q2 2026.
  • BCS Private Wealth Management sold 429 Eli Lilly shares in Q2 2026, an estimated $438K.
  • Eli Lilly made up 0.62% of BCS Private Wealth Management's portfolio in Q2 2026, its #43 holding.
  • BCS Private Wealth Management first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on BCS Private Wealth Management's 13F filing for Q2 2026, filed 31 Jul 2026.